Arbutus Biopharma Corp Earnings Per Share, Basic and Diluted
Arbutus Biopharma Corp (ABUS) reported Earnings Per Share, Basic and Diluted of -$1.00 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-04
CAD/shares
| Period end | Earnings Per Share, Basic and Diluted 12 month |
|---|---|
| 2011-12-31 | -0.88 CAD/shares 20-F · filed 2012-03-27 |
| 2010-12-31 | -1.20 CAD/shares 20-F · filed 2012-03-27 |
| 2009-12-31 | -0.85 CAD/shares 20-F · filed 2012-03-27 |
USD/shares
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$0.51 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$0.75 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$1.00 10-K · filed 2021-03-04 | |
| 2020-09-30 | -$0.27 10-Q · filed 2020-11-05 | -$0.52 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$0.77 10-Q · filed 2020-11-05 | -$1.21 derived: net income ÷ weighted average shares · filed 2021-11-04 | |
| 2020-06-30 | -$0.25 10-Q · filed 2020-08-07 | -$0.49 10-Q · filed 2020-08-07 | -$0.94 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$2.32 derived: net income ÷ weighted average shares · filed 2021-08-05 | |
| 2020-03-31 | -$0.25 10-Q · filed 2020-05-11 | -$0.70 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$2.12 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$2.59 derived: net income ÷ weighted average shares · filed 2021-05-05 | |
| 2019-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$1.95 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$2.41 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$2.89 10-K · filed 2021-03-04 | |
| 2019-09-30 | -$1.50 10-Q · filed 2020-11-05 | -$1.96 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$2.43 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | -$0.46 10-Q · filed 2020-08-07 | -$0.92 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | -$0.47 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | -$0.38 10-K · filed 2020-03-05 | -$1.21 10-K · filed 2020-03-05 | |||
| 2018-09-30 | -$0.49 10-Q · filed 2019-11-06 | -$0.49 10-K · filed 2020-03-05 | -$0.84 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | $0.01 10-K · filed 2020-03-05 | ||||
| 2018-03-31 | -$0.36 10-K · filed 2020-03-05 | ||||
| 2017-12-31 | -$0.67 10-K · filed 2019-03-07 | -$1.56 10-K · filed 2019-03-07 | |||
| 2017-09-30 | -$0.21 10-K · filed 2019-03-07 | -$0.55 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$0.89 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$0.33 10-K · filed 2019-03-07 | -$0.68 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | -$0.34 10-K · filed 2019-03-07 | ||||
| 2016-12-31 | -$4.05 10-K · filed 2018-03-16 | -$7.24 10-K · filed 2018-03-16 | |||
| 2016-09-30 | -$0.37 10-K · filed 2018-03-16 | -$3.15 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | -$2.47 10-K · filed 2018-03-16 | -$2.80 10-Q · filed 2017-08-03 | |||
| 2016-03-31 | -$0.31 10-K · filed 2018-03-16 | ||||
| 2015-12-31 | -$0.10 10-K · filed 2017-03-22 | -$1.34 10-K · filed 2017-03-22 | |||
| 2015-09-30 | -$0.57 10-K · filed 2017-03-22 | -$1.28 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | -$0.27 10-K · filed 2017-03-22 | -$0.64 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | -$0.40 10-K · filed 2017-03-22 | ||||
| 2014-12-31 | -$0.27 10-K · filed 2016-03-09 | -$1.80 10-K · filed 2016-03-09 | |||
| 2014-09-30 | -$0.39 10-K · filed 2016-03-09 | -$1.53 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | -$0.28 10-K · filed 2016-03-09 | -$1.15 10-Q · filed 2015-08-07 | |||
| 2014-03-31 | -$0.91 10-K · filed 2016-03-09 | ||||
| 2013-12-31 | -$0.15 10-K · filed 2015-03-13 | -$0.92 10-K · filed 2015-03-13 | |||
| 2013-09-30 | -$0.41 10-K · filed 2015-03-13 | -$0.79 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | -$0.21 10-K · filed 2015-03-13 | -$0.39 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | -$0.18 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |